Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Coller

Showing results (21-30 of 163) with videos related to

Pageof 17
Sort By:
The Journal of Clinical Investigation|December 31, 1997
Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeuticsB S Coller
Circulation|December 24, 1997
Monitoring platelet GP IIb/IIIa [corrected] antagonist therapyB S Coller
The Journal of Clinical Investigation|July 1, 1985
A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complexB S Coller
Thrombosis and Haemostasis|August 7, 2001
Anti-GPIIb/IIIa drugs: current strategies and future directionsB S Coller
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 10, 1999
Monitoring platelet GPIIb/IIIa antagonist therapyB S Coller
Thrombosis and Haemostasis|July 1, 1997
GPIIb/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 FabB S Coller
Lancet (London, England)|April 7, 1984
Bizzozero and the discovery of the blood plateletB S Coller
Lancet (London, England)|November 26, 1988
Thromboembolism and air travelB S Coller
Coronary Artery Disease|December 1, 1995
Augmentation of thrombolysis with antiplatelet drugsB S Coller
European Heart Journal|November 1, 1995
The role of platelets in arterial thrombosis and the rationale for blockade of platelet GPIIb/IIIa receptors as antithrombotic therapyB S Coller
Pageof 17

Showing results (21-30 of 163) with videos related to

Sort By:
Pageof 17
The Journal of Clinical Investigation|December 31, 1997
Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeuticsB S Coller
Circulation|December 24, 1997
Monitoring platelet GP IIb/IIIa [corrected] antagonist therapyB S Coller
The Journal of Clinical Investigation|July 1, 1985
A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complexB S Coller
Thrombosis and Haemostasis|August 7, 2001
Anti-GPIIb/IIIa drugs: current strategies and future directionsB S Coller
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 10, 1999
Monitoring platelet GPIIb/IIIa antagonist therapyB S Coller
Thrombosis and Haemostasis|July 1, 1997
GPIIb/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 FabB S Coller
Lancet (London, England)|April 7, 1984
Bizzozero and the discovery of the blood plateletB S Coller
Lancet (London, England)|November 26, 1988
Thromboembolism and air travelB S Coller
Coronary Artery Disease|December 1, 1995
Augmentation of thrombolysis with antiplatelet drugsB S Coller
European Heart Journal|November 1, 1995
The role of platelets in arterial thrombosis and the rationale for blockade of platelet GPIIb/IIIa receptors as antithrombotic therapyB S Coller
Pageof 17